A MULTI-CENTER, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, THIRD PARTY OPEN, PLACEBO CONTROLLED, PILOT STUDY TO ASSESS THE URODYNAMIC EFFECTS OF MODIFIED RELEASE UK-369,003 IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS)
Phase 2
Completed
- Conditions
- 10046590miction problems
- Registration Number
- NL-OMON30658
- Lead Sponsor
- Pfizer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 8
Inclusion Criteria
age <=> 40 years
LUTS with definition IPSS <=> 13 score
with clinical diagnosis of BPH
(see protocol page 13)
Exclusion Criteria
prostate cancer
documentation of urine infection
use of certain medication(s) and/or operation(s)
(see protocol 13-16)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method